## Abstract ## Purpose To present a novel fully automated method for assessing the quality of magnetic resonance imaging (MRI) data acquired in a clinical trials environment. ## Materials and Methods This work was performed in the context of clinical trials for multiple sclerosis. Quality contro
Automated quality control protocol for MR spectra of brain tumors
✍ Scribed by Alan J. Wright; Carles Arús; Jannie P. Wijnen; Angel Moreno-Torres; John R. Griffiths; Bernardo Celda; Franklyn A. Howe
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 581 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
eTUMOUR (http://www.etumour.net/) is acquiring a large database of brain tumor ^1^H MR spectra to develop automated pattern recognition methods and decision support system (DSS) for tumor diagnosis. Development of accurate pattern‐recognition algorithms requires spectra undistorted by artifacts, low signal‐to‐noise, or broad lines. eTUMOUR currently uses panels of expert spectroscopists to subjectively grade spectra as being acceptable or unacceptable. Automated quality control (QC) would be more satisfactory for several reasons: 1) to provide a reproducible objective classification of spectrum quality; 2) for use within the future DSS to prevent misdiagnosis due to poor spectrum quality; 3) to rapidly process the very large datasets of ^1^H spectra being accrued. An automated QC method using independent component analysis for feature extraction with a least‐squares support vector machine classifier is presented. Separate training (n = 144) and test sets (n = 98) of single‐voxel spectra from brain tumors and other lesions were acquired at multiple clinical centers with short and long echo times. Pairs of expert spectroscopists classified the test set an average of 85% the same. The automated QC classification agreed with an expert for 87% of test spectra, on average, suggesting the method classifies spectrum quality as accurately as expert spectroscopists. Magn Reson Med 59:1274–1281, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Recent studies have shown that MRS can substantially improve the non-invasive categorization of human brain tumours. However, in order for MRS to be used routinely by clinicians, it will be necessary to develop reliable automated classification methods that can be fully validated. This paper is in t
## Abstract This study examines the effect of feature extraction methods prior to automated pattern recognition based on magnetic resonance spectroscopy (MRS) for brain tumor diagnosis. Since individual inspection of spectra is time‐consuming and requires specific spectroscopic expertise, the intro